Inhibition of nitric oxide and inflammatory cytokines in LPS-stimulated murine macrophages by resveratrol, a potent proteasome inhibitor

Lipids in Health and Disease

Volumn 11, Issue , 2012, Pages

  Qureshi, Asaf A ^a   Guan, Xiu Qin ^a   Reis, Julia C ^a,b   Papasian, Christopher J ^a   Jabre, Sandra ^c   Morrison, David C ^a   Qureshi, Nilofer ^a,b  

^a UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Cytokines; NF B; Nitric oxide (NO); Proteasome inhibitors; Resveratrol; TNF

Indexed keywords

CHYMOTRYPSIN TRYPSIN; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; INTERLEUKIN 6; MORIN HYDRATE; NICOTINIC ACID; NITRIC OXIDE; PROTEASOME INHIBITOR; PTEROSTILBENE; RESVERATROL; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BLUEBERRY; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DRUG EFFECT; ENZYME INHIBITION; GRAPE; HUMAN; HUMAN CELL; MACROPHAGE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; RED WINE;

ANIMALS; CELL LINE; CYTOKINES; ENZYME INHIBITORS; FLAVONOIDS; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; NF-KAPPA B; NITRIC OXIDE; STILBENES; TUMOR NECROSIS FACTOR-ALPHA;

MURINAE; MUS; VACCINIUM; VITACEAE;

EID: 84862180074     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-11-76     Document Type: Article

References (29)

1. Interactive role of infection, inflammation andtraditional risk factors in atherosclerosis and coronary artery disease. Mehta JL, Saldeen TGP, Rand K, J Am Coll Cardiol 1998 31 1217 1225 10.1016/S0735-1097(98)00093-X 9581711 (Pubitemid 28219109)
2. Novel inflammatory markers of coronary risk. Theory versus practice. Libby P, Ridker PM, Circulation 1999 100 1148 1150 10.1161/01.CIR.100.11.1148 10484532 (Pubitemid 29426587)
3. Tocotrienols in health and diseases: The other half of the natural vitamin E family. Sen CK, Khanna S, Roy S, Molecular aspect of Medicine. 2007 28 692 728 10.1016/j.mam.2007.03.001 (Pubitemid 47625534)
4. Altered regulation of inducible nitric oxide synthase expression in macrophages from senescent mice. Chen LC, Pace JL, Russell SW, Morrison DC, Infect Immun 1996 64 10 4288 4298 8926101 (Pubitemid 26318155)
5. Suppression of nitric oxide production and pro-inflammatory cytokines by novel proteasomes inhibitors in various experimental models. Qureshi AA, Tan X, Reis JC, Badr MZ, Papasian CJ, Morrison DC, Qureshi N, Lipids in Health and Disease 2011 10 177 10.1186/1476-511X-10-177 21992595
6. -Tocotrienol and quercetin reduce serum levels of nitric oxide and lipid parameters in female chickens. Qureshi AA, Reis JC, Qureshi N, Papasian CJ, Morrison DC, Schaefer DM, Lipids in Health and Disease 2011 10 39 10.1186/1476-511X-10-39 21356098
7. Tocotrienols inhibit lipopolysacharide-induecd pro-inflammatory cytokines in macrophages of female mice. Qureshi AA, Reis JC, Papasian CJ, Morrison DC, Qureshi N, Lipids in Health and Disease 2010 9 143 10.1186/1476-511X-9-143 21162750
8. Why heart disease mortality is low in France. Law M, Wald N, British Medical Journal 1999 318 1471 1480 10.1136/bmj.318.7196.1471 10346778
9. The French Paradox; Lessons for other countries. Ferrieres J, Heart 2004 90 1 107 111 10.1136/heart.90.1.107 14676260 (Pubitemid 38064560)
10. Resveratrol provides late-phase cardioprotection by means of a nitric oxide- and adenosine-mediated mechanism. Bradamante S, Barenghi L, Piccinini F, Bertelli AAE, de Jonge R, Beemster P, de Jong JW, Eur J Phamacology 2003 465 115 123 10.1016/S0014-2999(03)01441-9 (Pubitemid 36332283)
11. Phamacometric of pterostilbene: Pre-clinical pharmacokinetics and metabolism, anticancer, anti-inflammatory, antioxidant and analgesic activity. Remsberg CM, Yanez JA, Ohgami Y, Vega-Villa KR, Rimando AM, Davies NM, Phytother Res 2008 22 169 179 10.1002/ptr.2277 17726731 (Pubitemid 351363234)
12. Effects of polyphenolic natural products on the lipid profiles of rats fed high fat diets. Yugarani T, Tan BKH, Reh M, Das NP, Lipids 1992 27 181 186 10.1007/BF02536175 1522762
13. The effects of plant flavonoids on mammalian cells: Implications for inflammation, heart disease, and cancer. Middleton E, Kandaswami C, Theoharides TC, Pharmacol Rev 2000 52 4 673 751 11121513
14. Federal Food, Drug and Cosmetic Act, Tocotrienols (TRF) is Generally Recognized as Safe (GRAS), Title 21 Code of Federal Regulations (21 CFR). 2010. May 18, 2010. U.S. Food and Drug Administration Silver Spring, 10903 New Hamshire Avenue AA MD. 20993
15. Complete structural determination of lipopolysaccharide obtained from deep rough mutant of Escherichia coli. Purification by high performance liquid chromatography and direct analysis by plasma desorption mass spectrometry. Qureshi N, Takayama K, Mascagni P, Honovich J, Wong R, Cotter RJ, J Biol Chem 1988 263 11971 11976 3136169
16. Proteasome inhibitor, lactacystin blocks CpG DNA- and peptidoglycan induced inflammatory genes, cytokines and mitogen-activated protein kinases in macrophages. Shen J, Gao JJ, Zhang G, Tan X, Morrison DC, Papasian CJ, Vogel SN, Qureshi N, Shock 2006 25 594 599 10.1097/01.shk.0000209555.46704.2d 16721267 (Pubitemid 44297020)
17. Regulation of cellular caveolin-1 protein expression in murine macrophages by microbial products. Lei MG, Tan X, Qureshi N, Morrison DC, Infect Immun 2005 73 8136 8143 10.1128/IAI.73.12.8136-8143.2005 16299308 (Pubitemid 41740301)
18. Nitric oxide: a macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells. Stuehr DJ, Nathan CF, J Exp Med 1989 169 1543 1555 10.1084/jem.169.5.1543 2497225 (Pubitemid 19126814)
19. Analysis of TLR4 polymorphic variants: New insight into TLR4/MD-2/CD14 stoichiometry, structure, and signaling. Rallabhandi P, Bell J, Boukhvalova MS, Medvedev A, Lorenz E, Arditi M, Hemming VG, Balnco JCG, Segal DA, Vogel SN, J Immunol 2006 177 322 332 16785528 (Pubitemid 43939144)
20. Rapid colorimetric assay for cell growth and survival. Modification to the tetrazolium dye procedure giving improved sensibility and reliability. Denizot F, Lang R, J Immunol Methods 1986 89 271 277 10.1016/0022-1759(86)90368- 6 3486233 (Pubitemid 16080782)
21. Single step method of RNA isolation by acid guaninium-phenol-chloroform extraction. Chomczynski P, Saachi N, Ana Biochem 1987 162 156 159 (Pubitemid 17064313)
22. LPS-induced formation of immune-proteasome: TNF- and nitric oxide production are regulated by altered composition of proteasome-active sites. Reis J, Guan XQ, Kisselev AF, Papasian CJ, Qureshi AA, Morrison DC, Van Way CW, Vogel SN, Qureshi N, Cell Biochemistry and Biophysics 2011 60 77 88 10.1007/s12013-011-9182-8 21455682
23. The immunoproteasome regulate LPS-inducedTRIF/TRAM signaling pathway in murine macrophages. Reis J, Hassan F, Guan XQ, Shen J, Monaco JJ, Papasian CJ, Qureshi AA, Van Way CW, Vogel SN, Morrison DC, Qureshi N, Cell Biochemistry and Biophysics 2011 60 119 126 10.1007/s12013-011-9183-7 21455681
24. Naturally-occurring NF-B inhibitors. Nam N, Mini-Reviews in Medicinal Chemistry 2006 6 945 951 10.2174/138955706777934937 16918500 (Pubitemid 44194381)
25. The proteasome: A central regulator of inflammation and macrophage function. Qureshi N, Vogel SN, Way CV, Papasian CJ, Qureshi AA, Morison DC, Immunological Research 2005 31 3 243 260 10.1385/IR:31:3:243 (Pubitemid 40628961)
26. Inhibition of Nod2 signaling and target geneepression by curcumin. Huang S, Zhao L, Kim K, Lee DS, Hwang DH, Mol Phamacol 2008 74 274 281 (Pubitemid 351872178)
27. Inhibition of nitric oxide in LPS-stimulated macrophages of young and senescent mice by - tocotrienol and quercetin. Qureshi AA, Tan X, Reis JC, Badr MZ, Papasian CJ, Morrison DC, Qureshi N, Lipids in Health and Disease 2011 10 239 10.1186/1476-511X-10-239 22185406
28. Nuclear factor kappa B: a pivotal transcription factor in chronic inflammatory diseases. Barnes PJ, Karin M, New Eng J Med 1997 336 1066 1071 10.1056/NEJM199704103361506 9091804 (Pubitemid 27163860)
29. Specific inhibition of MyD88-independent signaling pathways of TLR3 and TLR4 by resveratrol: Molecular targets are TBK1 and RIP1 in TRIF complex. Youn HS, Lee JY, Fitzgerald KA, Young HA, Akira S, Hwang DH, J Immunol 2005 175 3339 3346 16116226 (Pubitemid 41170555)